Progyny Q1 rev $328.5M (+1.4%), adj EPS $0.50; guides FY rev $1.365-1.405B

Progyny, Inc.

2026-Q1 EPS reported $0.29 revenue$328,504,000

Q1 revenue $328.5M (+1.4% YoY); ex-lost client revenue grew 12.2%. Net income $24.2M ($0.29 diluted) vs $15.1M.
Gross margin improved to 25.3% from 23.4%; Adjusted EBITDA $56.6M (17.2% margin) vs $57.8M (17.8%).
Completed $200M buyback; repurchased 8.8M shares total. Board evaluating new program, decision by end of May.
Client count 595 (up 63 YoY); covered lives ~7.2M. ART cycles 15,647 vs 16,160 (transition impact).
FY 2026 guidance: rev $1.365-1.405B, adj EBITDA $232-244M, adj EPS $1.98-2.09. Q2: rev $342-355M.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Progyny, Inc. reported the three-month period ended March 31, 2026 results: revenue $328,504, net income $24,232, EPS $0.29.

Period: the three-month period ended March 31, 2026
Revenue: $328,504
Net income: $24,232
EPS: $0.29
Result: reported results

Exact text from the filing

returned value to our investors by repurchasing 8.8 million shares.” First Quarter 2026 Highlights: (unaudited; in thousands, except per share amounts) 1Q 2026 1Q 2025 Revenue $328,504 $324,038 Gross Profit $83,071 $75,795 Gross Margin 25.3% 23.4% Net Income $24,232 $15,059 Net Income per Diluted Share 1 $0.29 $0.17 Adjusted Earnings per Diluted Share 2 $0.50

View on SEC.gov

Browse all earnings releases →

Progyny, Inc. filing history →

Source: SEC EDGAR

accession 0001551306-26-000062

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.